27 Mar 2007
Exclusive License Agreement for Modified Release Beraprost Assumed and Restated by Lung Rx, Inc.
SILVER SPRING, Md., March 27 /PRNewswire-FirstCall/ -- Lung Rx, Inc., a
wholly-owned subsidiary of United Therapeutics Corporation (Nasdaq: UTHR),
today announced that it has entered into an...
26 Feb 2007
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
SILVER SPRING, Md., Feb. 26 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced new guidance from pulmonary
arterial hypertension opinion leaders relating to...
SILVER SPRING, Md., Feb. 20 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the fourth
quarter and year ended December 31, 2006. "We...
SILVER SPRING, Md., Feb. 13 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) announced today that it will release its 2006
fourth quarter and annual financial results before...
12 Dec 2006
United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial for Pulmonary Arterial Hypertension
SILVER SPRING, Md. and SATELLITE BEACH, Fla., Dec. 12
/PRNewswire-FirstCall/ -- Lung Rx, Inc., a wholly-owned subsidiary of United
Therapeutics Corporation (Nasdaq: UTHR), announced that its...
SILVER SPRING, Md., Nov. 13 /PRNewswire/ -- United Therapeutics Corporation
(Nasdaq: UTHR) announced today that its wholly owned subsidiary Unither Pharma,
Inc. has settled all patent litigation with...
SILVER SPRING, Md., Oct. 31 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the quarter
ended September 30, 2006. "We are pleased to...
SILVER SPRING, Md., Oct. 24 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced the pricing of $210 million
principal amount of Convertible Senior Notes due 2011...
SILVER SPRING, Md., Oct. 23 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) is announcing a 4,000,000 share repurchase program,
third quarter 2006 summary financial results...